ViewRay (VRAYQ) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock VRAYQ vs. SDCCQ, AFIB, GMVDF, NMRD, UTRS, MOTS, VIVE, DRTSW, ANZUW, and ATAKWShould you be buying ViewRay stock or one of its competitors? The main competitors of ViewRay include SmileDirectClub (SDCCQ), Acutus Medical (AFIB), G Medical Innovations (GMVDF), Nemaura Medical (NMRD), Minerva Surgical (UTRS), Motus GI (MOTS), Viveve Medical (VIVE), Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), and Aurora Technology Acquisition (ATAKW). These companies are all part of the "medical equipment" industry. ViewRay vs. Its Competitors SmileDirectClub Acutus Medical G Medical Innovations Nemaura Medical Minerva Surgical Motus GI Viveve Medical Alpha Tau Medical Anzu Special Acquisition Corp I Aurora Technology Acquisition ViewRay (NASDAQ:VRAYQ) and SmileDirectClub (NASDAQ:SDCCQ) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, earnings, media sentiment, risk, profitability, analyst recommendations and dividends. Do insiders & institutionals believe in VRAYQ or SDCCQ? 15.5% of ViewRay shares are held by institutional investors. Comparatively, 0.1% of SmileDirectClub shares are held by institutional investors. 2.5% of ViewRay shares are held by company insiders. Comparatively, 64.7% of SmileDirectClub shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Does the media refer more to VRAYQ or SDCCQ? In the previous week, ViewRay's average media sentiment score of 0.00 equaled SmileDirectClub'saverage media sentiment score. Company Overall Sentiment ViewRay Neutral SmileDirectClub Neutral Is VRAYQ or SDCCQ more profitable? Company Net Margins Return on Equity Return on Assets ViewRayN/A N/A N/A SmileDirectClub N/A N/A N/A Which has preferable valuation and earnings, VRAYQ or SDCCQ? SmileDirectClub has higher revenue and earnings than ViewRay. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioViewRay$102.21M0.00-$107.33MN/AN/ASmileDirectClub$470.74M0.00-$86.40MN/AN/A Which has more risk and volatility, VRAYQ or SDCCQ? ViewRay has a beta of 1.05, meaning that its share price is 5% more volatile than the S&P 500. Comparatively, SmileDirectClub has a beta of 1.76, meaning that its share price is 76% more volatile than the S&P 500. SummarySmileDirectClub beats ViewRay on 4 of the 5 factors compared between the two stocks. Get ViewRay News Delivered to You Automatically Sign up to receive the latest news and ratings for VRAYQ and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VRAYQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip Chart VRAYQ vs. The Competition Export to ExcelMetricViewRayElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$18K$41.65M$6.17B$10.57BDividend YieldN/AN/A5.73%4.78%P/E RatioN/A3.6885.8227.46Price / SalesN/A209.73579.16187.21Price / CashN/A41.3637.4661.86Price / BookN/A2.7012.696.82Net Income-$107.33M-$2.66M$3.32B$276.90M ViewRay Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VRAYQViewRayN/AN/AN/AN/A$18K$102.21M0.00300SDCCQSmileDirectClubN/A$0.00flatN/AN/A$40K$470.74M0.002,700AFIBAcutus MedicalN/A$0.00+100.0%N/A-99.7%$30K$7.16M0.00340GMVDFG Medical InnovationsN/AN/AN/A-50.0%$26K$4.42M0.0072NMRDNemaura Medical0.6184 of 5 stars$0.00flatN/AN/A$4K$3.02K0.0040UTRSMinerva SurgicalN/AN/AN/AN/A$1K$51.69M0.00160MOTSMotus GI0.0277 of 5 starsN/AN/AN/A$1K$319K0.0030VIVEViveve MedicalN/A$0.00-50.0%N/A-80.0%$1K$6.83M0.0070Gap DownHigh Trading VolumeDRTSWAlpha Tau MedicalN/A$0.36-8.8%N/A+76.3%$0.00N/A0.0080Positive NewsANZUWAnzu Special Acquisition Corp IN/A$0.06-28.2%N/AN/A$0.00N/A0.002Gap DownHigh Trading VolumeATAKWAurora Technology AcquisitionN/A$0.01-24.0%N/A-46.7%$0.00N/A0.00N/AGap Down Related Companies and Tools Related Companies SmileDirectClub Alternatives Acutus Medical Alternatives G Medical Innovations Alternatives Nemaura Medical Alternatives Minerva Surgical Alternatives Motus GI Alternatives Viveve Medical Alternatives Alpha Tau Medical Alternatives Anzu Special Acquisition Corp I Alternatives Aurora Technology Acquisition Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VRAYQ) was last updated on 10/16/2025 by MarketBeat.com Staff From Our PartnersBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredOptions Pro Reveals His #1 Retirement Income TradeIf you can be at your computer between 9 a.m. and 10:45 a.m. on most weekdays, I’ll show you a simple trading ...Base Camp Trading | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredNvidia’s slow death marchEric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ViewRay, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ViewRay With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
